All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

*** 

Did you know there are now 10 cases of cancer after COVID-19 mRNA vaccination in the literature? Here they are:

“Turbo Cancer” post mRNA vaccine papers reviewed: 

New paper by Dr. Stefanie Seneff and Dr. Peter McCullough

• 56 year old man had 1st Pfizer mRNA dose


• 4 days later he started having right TMJ pain which worsened over time


• 2 months after Pfizer he was diagnosed with right-sided trigeminal neuralgia and cranial nerve VII palsy


• 4 months after Pfizer he started losing weight, lost 12 kg


• 8 months after Pfizer he had deafness in right ear, couldn’t open right eye, couldn’t open right side of his mouth, total paralysis of right face and a large mass blocking the external auditory canal – diagnosed as basaloid cell carcinoma


• 15 months after Pfizer (1st picture above – extreme cavitation in the preauricular region, extreme necrosis of the skin and extensive infiltrations of vasculature)

May 2023 – Eens et al – Mouse develops lymphoma after 2nd Pfizer mRNA

• I don’t count this as part of the 10 cases but I include it here for completeness


• They injected 14 mice with two Pfizer COVID-19 mRNA vaccines.


• Two days after the 2nd dose and 16 days after 1st dose, one of the mice died suddenly without any warning.


• necropsy showed extensive, systemic infiltration of liver, kidneys, spleen, lungs, and intestines” by a lymphoma

April 2023 – Tachita et al – 73M develops lymphoma after 2nd Pfizer mRNA

• 73 year old Japanese man presented with a lump in left arm where he had his 2nd Pfizer mRNA vaccine three months prior.


• he then developed 6cm and 3cm ulcerated lesions in the left arm


• he was diagnosed with Extranodal NK/T-cell lymphoma, nasal type (ENKL), a natural killer (NK) cell malignancy

Jan 2023 – Cavanna et al – 66M develops Stage 2 NHL lymphoma post 3rd Pfizer mRNA 

• 66 year old Italian man developed swollen right axillary lymph nodes 10 days after 3rd Pfizer mRNA (booster) dose.


• 3 months later he presented to the clinic with a 7cm mass in right axilla and 2cm lesion in right supraclavicular region


• He was diagnosed with a Stage 2 NHL Lymphoma, Ki-67 90%

Sep 2022 – Revenga-Porcel et al – 76M develops lymphoma after 3rd Moderna mRNA

• this paper is behind a paywall


• 76 year old man developed 7cm mass in right arm 10 days after 3rd Moderna mRNA


• diagnosed with PC-ALCL (very aggressive lymphoma – Primary cutaneous anaplastic large cell lymphoma (PCALCL) is a subtype of cutaneous T-cell lymphoma (CTCL), and is a non-Hodgkin lymphoma that arises in the skin

Aug 2022 – Sekizawa et al – 80F lymphoma after 2nd Pfizer mRNA 

• 80 year old Japanese woman developed a right temporal mass the day after 1st Pfizer mRNA


• she was given tylenol and took a 2nd Pfizer mRNA 3 weeks later


• she then presented again 3 weeks after 2nd Pfizer dose and mass was 3cm


• at around 13 weeks the mass grew to 7cm


• right temporal mass was diagnosed as a subtype of MZL (extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue or nodal marginal zone lymphoma) stage IIE

June 2022 – Zamfir et al – 58F and 53M develop lymphoma post 2nd Pfizer mRNA

• 58 year old Romanian woman developed 4cm left neck mass that appeared one week after 2nd Pfizer dose


• the 4cm mass and two lymph nodes were diagnosed DLBCL lymphoma, Ki-67 80%


• 53 year old Romanian man had 2 Pfizer mRNA vaccines


• On the third day after the first dose, he noticed a painless ulcer on the mucosal surface of the upper lip. He initiated self-treatment with topical vitamin A. The lesion extended and new lesions developed


• These lesions had a progressive character and during the following months were complicated with repetitive episodes of heavy oral bleeding, requiring blood transfusions. Biopsy confirmed the diagnosis of T/NK-cell lymphoma

Apr 2022 – Mitsui et al – 67M and 80F develop lymphoma post Pfizer mRNA

• 67 year old Japanese man presented with a 6 cm subcutaneous mass in the left axilla 2 weeks after 2nd Pfizer mRNA.


• Tenderness and a palpable lymph node in the left axilla were noted 1 day after 1st Pfizer mRNA


• He was diagnosed with DLBCL Lymphoma with Ki-67 > 80%

• 80-year-old Japanese woman presented with a 4cm enlarging nodule in her left axilla 1 day after 2nd Pfizer mRNA


• The nodule appeared 2  days after the first vaccination.


• Two months after the first consultation, the nodule gradually enlarged, and computed tomography revealed a 6.0-cm mass in the left axilla and another 2.8-cm mass in the left mesentery


• she was diagnosed with germinal centre B-cell DLBCL lymphoma, Ki-67 > 90%


• patient complained of diplopia and left eyelid ptosis 8  days after the biopsy. Magnetic resonance imaging detected a small tumour, a suspicious DLBCL lesion, in the left cavernous sinus, which was treated with radiation therapy

Nov. 2021 – Goldman et al – 66M lymphoma progression after Pfizer booster 

• 66 year old man had 2 Pfizer mRNA doses and 5 months after 2nd dose presented with axillary lesions


• He was diagnosed with Angioimmunoblastic T Cell Lymphoma


• He then had a Pfizer mRNA booster shot and a few days later presented with neck swelling.


• A repeat PET/CT scan done 8 days after Pfizer mRNA 3rd dose (booster) showed extensive progression of lymphoma.

The goal of this article was to bring together all the cases of COVID-19 mRNA vaccine induced Turbo Cancer in the literature.

There are now 10 published cases. And this is only the beginning.

When the dam finally breaks, there will be 100s, then 1000s of these cases.

Right now it’s mostly lymphomas.

But I am seeing Turbo Cancers with lymphomas, brain cancers, breast, colon and lung cancers as the top 5, with signals in leukemias and hepatobiliary cancers.

I will not cover the possible mechanisms here but I will point out that Ki-67 is extremely important.

Ki-67 is a proliferation index determined with special staining during pathology, and a Ki-67 of 90% means 90 out of 100 cells are dividing.

It indicates how rapidly growing a tumor is. 90% is extreme.

“Tumors with a high Ki-67 index have a larger number of proliferating cells and are therefore likely to grow more quickly”

It also predicts long term survival in a number of cancers.

A high Ki-67 usually carries a very poor prognosis.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Dr. William Makis is a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar. Author of 100+ peer-reviewed medical publications.

Featured image is from Children’s Health Defense

---